Sponsor:
Biohaven Therapeutics Ltd.
Code:
NCT06384807
Conditions
Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BHV-1510
Cemiplimab
BHV-1510
BHV-1510
Cemiplimab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Biohaven Therapeutics Ltd. on 2025-08-03.